Scribe Therapeutics Inc. (SCTX) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Scribe Therapeutics Inc. (SCTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $309.4M, listed on NASDAQ, employing roughly 89 people, carrying a beta of 0.00 to the broader market. Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. Led by Benjamin L. Oakes, public since 2026-07-24.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for SCTX as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →